Get it on Google Play

Kensey Nash (KNSY) Received 510(k) Clearance From FDA For ThromCat

April 27, 2006 10:42 AM EDT Send to a Friend
Kensey Nash (Nasdaq: KNSY) announced that it has received 510(k) clearance for its ThromCat Thrombectomy Catheter System from the U.S ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login